CDSCO Flags 55 Substandard, 4 Spurious Drugs in June Batch Alert, Full List Inside Farhat Nasim19 July 2025 3:00 PM ISTNew Delhi: In its latest regulatory update for June 2025, the Central Drugs Standard Control Organisation (CDSCO) has flagged a total of 55 drug...
Zydus Asked to Revise Phase III Trial Protocol for Cough Syrup FDC After CDSCO Panel Review Dr. Divya Colin18 July 2025 9:52 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended key revisions to the Phase...
Expert Drug Panel Clears Proposal to Amend Licensing Forms for Advanced Biologics, Xenografts Parthika Patel16 July 2025 4:15 PM ISTNew Delhi: The apex advisory body functioning under the Central Drugs Standard Control Organisation (CDSCO), Drugs Consultative Committee (DCC),...
No Eligible Successor: Centre Clarifies DCGI's Contractual Reappointment Farhat Nasim15 July 2025 9:30 PM ISTNew Delhi: Amid an ongoing legal challenge in the Madurai High Court, the Central government has clarified that its decision to reappoint Dr Rajeev...
Zydus Gets SEC Nod to Begin Phase IV Trial of Dydrogesterone ER for Habitual Miscarriage Parthika Patel15 July 2025 8:21 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organisation (CDSCO) has granted...
CDSCO Panel Approves GSK's Proposal to Double Indian Patient Pool in Dostarlimab Trial Parthika Patel15 July 2025 7:34 PM ISTNew Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control...
Do Not Issue Licenses Without New Drug Permission from DCGI, Govt Panel Tells States Farhat Nasim14 July 2025 11:28 PM ISTNew Delhi: In a move to reinforce coordination between central and state drug regulatory bodies, the Drugs Consultative Committee (DCC) has called on...
Pfizer Gets CDSCO Panel Nod To Conduct Phase III Trial of RSV Vaccine in India, Told to Clarify Subject Criteria Dr. Divya Colin13 July 2025 1:00 PM ISTNew Delhi: Pfizer has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Unreadable Expiry Dates, Generic Mix-Ups: Govt Panel Proposes Forming Sub-Committee on Medicine Labelling Farhat Nasim12 July 2025 8:25 PM ISTNew Delhi: In a move responding directly to widespread consumer grievances, the Drugs Consultative Committee (DCC), a statutory body under the Central...
SEC Flags Safety, Efficacy Gaps in Troikaa's Rapid IV Paracetamol Bolus Proposal, Seeks More Data Parthika Patel12 July 2025 7:59 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has declined to approve Troikaa...
Cipla Secures CDSCO Panel Nod to Manufacture Amantadine Oral Solution with Trial Waiver Dr. Divya Colin10 July 2025 7:05 PM ISTNew Delhi: Drug major Cipla has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Recommends Phase IV Trial for Acne FDC Gel by Precise Biopharma Parthika Patel9 July 2025 11:37 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs Standard Control Organisation (CDSCO)...
